source
- Gilead reports positive Phase 2 results for oral ulcerative colitis drugGilead announced that its experimental oral therapy for ulcerative colitis achieved positive results in a Phase 2 trial. The study reported that patients receiving the drug showed measurable clini…
- Saudi Arabia rolls out biotech partnerships to support its $34.6 billion non‑oil growth planSaudi Arabia’s National Biotechnology Strategy, launched in early 2024, aims to add $34.6 billion to non‑oil GDP by 2040 and create 11,000 jobs by 2030. The plan is now moving beyond policy into co…